Dimopoulos, M.A. Beksac, M. Benboubker, L. Roddie, H. Allietta, N. Broer, E. Couturier, C. Mazier, M.-A. Angermund, R. Facon, T., Phase II study of bortezomib-dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myeloma, Haematologica-the hematology journal, (98), 1264-1272, 2013,